Hex-5-1-(6H-phenanthridin-5-yl)-hex-5-en-1-one, 23. Yield:
68% as a yellow oil. νmax(thin film)/cm-1 1657 (CO). Found: C,
82.35; H, 6.98; N, 5.01. Calcd for C19H19NO: C, 82.28; H, 6.90;
N, 5.05. δH (270 MHz, CDCl3) 1.65-1.76 (2H, m), 1.90-2.08 (2H,
m), 2.48 (2H, t, J 7.4), 4.81-4.88 (4H, m), 5.60-5.67 (1H, m),
7.20-7.42 (6H, m), 7.76-7.81 (2H, m); δC (100 MHz, CDCl3)
24.8, 33.1, 45.2, 114.9, 123.3, 124.5, 124.7, 126.2, 127.6, 128.0,
129.9, 131.9, 135.3, 137.8, 138.0, 172.2; m/z (EI) 277 (M+, 28%),
180 (100%).
Hydrogenation of Double Bonds. A mixture of 10% Pd/C (190
mg, 0.5 equiv) and the appropriate benzolactam (0.36 mmol, 1.0
equiv) in ethanol (3.6 mL, 0.1 M) was stirred under a hydrogen
atmosphere at room temperature for 18 h. Subsequently, the
suspension was filtered through a short plug of silica and the
solution was concentrated in vacuo to furnish the products.
1-Benzyl-4-propyl-3,4-dihydro-1H-quinolin-2-one, 18. δH (400
MHz, CDCl3) 0.91 (3H, t, J 7.2), 1.25-1.39 (1H, m), 1.40-1.51
(1H, m), 1.53-1.75 (2H, m), 2.69-2.74 (1H, m), 2.88-2.95 (2H,
m), 5.01 (1H, d, J 16.2), 5.35 (1H, d, J 16.2), 6.89 (1H, d, J 8.1),
6.98 (1H, t, J 7.4), 7.08-7.17 (2H, m), 7.21-7.32 (5H, m); δC
(100 MHz, CDCl3) 14.0, 20.1, 35.9, 36.0, 37.0, 46.0, 115.8, 122.8,
126.5, 127.0, 127.3, 127.8, 128.7, 130.1, 137.1, 138.9, 169.9; m/z
(EI) 279 (M+, 56%), 236 (39%), 91 (100%).
Experimental Section
General Procedure for Preparation of 10-12, under “Stan-
dard” Heck Reaction in the Presence of PPh3. A Young’s tube
was charged with Pd(dba)2 (14 mg, 0.025 mmol, 5 mol %), PPh3
(26 mg, 0.099 mmol, 20 mol %), and LiCl (23 mg, 0.54 mmol, 1.1
equiv. Note: this is optional). To this was added Et3N (0.137 mL,
0.98 mmol, 2.0 equiv), dry DMF (4 mL), and the appropriate amide
(0.49 mmol, 1.0 equiv) as a solution in dry DMF (1 mL). The vessel
was sealed by a PTFE tap and the reaction stirred at room
temperature for 15 min, followed by heating at 130 °C for 22 h.
After this time, the reaction mixture was cooled and filtered through
Celite. The solution was then concentrated and purified by column
chromatography.
1-Benzyl-4-methyl-1H-quinolin-2-one, 10. Recrystallized from
hexane after column chromatography. Yield: 87% as a yellow
crystalline solid; Rf ) 0.16 (hexane/ethyl acetate, 2/1); mp 110-
111 °C (lit.24 110.5-111.5 °C); νmax(KBr)/cm-1 1651 (CdO); δH
(270 MHz, CDCl3) 2.51 (3H, s), 5.56 (2H, s), 6.71 (1H, s), 7.20-
7.31 (7H, m), 7.42 (1H, t, J 7.9), 7.72 (1H, d, J 7.9); δC (100 MHz,
CDCl3) 19.1, 45.7, 115.3, 121.0, 121.7, 122.0, 125.3, 126.5, 127.2,
128.8, 130.4, 136.5, 139.1, 147.1, 162.3; m/z (EI) 249 (M+, 100%),
248 (72%), 143 (65%), 91 (72%).
1-Benzyl-5-methylene-1,3,4,5-tetrahydro-1-benzazepin-2-
one, 11. Yield: 85% as a pale yellow solid; Rf ) 0.28 (hexane/
ethyl acetate, 2/1); mp 89-90 °C; νmax(KBr)/cm-1 1651 (CdO).
Found: C, 81.94; H, 6.54; N, 5.22. Calcd for C18H17NO: C, 82.10;
H, 6.51; N, 5.32. δH (270 MHz, CDCl3) 2.56 (2H, t, J 6.9), 2.98-
3.01 (2H, m), 4.83 (1H, dt, J 1.6, 1.9), 5.01 (2H, s), 5.15 (1H, dt,
J 1.6, 1.9), 7.12-7.27 (9H, m, ArH); δC (100 MHz, CDCl3) 33.0,
36.3, 51.3, 115.5, 122.6, 126.4, 127.0, 127.7, 128.2, 128.5, 129.0,
137.5, 137.6, 140.8, 145.2, 173.0; m/z (EI) 263 (M+, 63%), 172
(30%), 144 (33%), 130 (27%), 91 (100%).
1-Benzyl-6-methylene-3,4,5,6-tetrahydro-1H-benzazocin-2-
one, 12. Yield: 72% as a pale yellow solid; Rf ) 0.19 (hexane/
ethyl acetate, 3/1); mp 65-66 °C; νmax(KBr)/cm-1 1658 (CO).
Found: C, 82.16; H, 6.84; N, 4.96. Calcd for C19H19NO: C, 82.28;
H, 6.90; N, 5.05. δH (270 MHz, CDCl3) 1.84-1.94 (2H, m), 2.00-
2.21 (2H, m), 2.31-2.38 (1H, m), 2.54-2.62 (1H, m), 4.00 (1H,
d, J 1.5), 4.83 (1H, d, J 14.3), 4.89 (1H, m), 4.99 (1H, d, J 14.3),
7.10-7.17 (2H, m) 7.19-7.28 (7H, m); δC (100 MHz, CDCl3) 26.1,
33.1, 36.8, 52.7, 115.5, 125.6, 127.3, 127.3, 127.8, 128.1, 129.2,
129.3, 137.0, 139.6, 142.8, 145.9, 173.6; m/z (EI) 277 (M+, 90%),
186 (61%), 91 (100%).
General Procedure for Cyclization under “Ligandless” Con-
ditions. A Young’s tube was charged with Pd(OAc)2 (6 mg, 0.025
mmol, 5 mol %), n-Bu4NCl (137 mg, 0.49 mmol, 1.0 equiv) and
KOAc (121 mg, 1.23 mmol, 2.5 equiv). To this was added the
appropriate amide (0.49 mmol, 1.0 equiv), followed by dry DMF
(5 mL). The vessel was sealed with a PTFE tap and the reaction
mixture was stirred at room temperature for 10 min, followed by
heating at 130 °C for 22 h. After this time, the reaction mixture
was cooled and filtered through Celite. The solvent was removed
under vacuum, and the product purified by column chromatography.
1-Benzyl-5-methyl-1,3-dihydro-1-benzazepin-2-one, 22. Com-
pound was not isolated but obtained as inseparable mixture with
11. δH (270 MHz, CDCl3) 2.10 (3H, s), 2.63-2.66 (1H, m), 3.06-
3.14 (1H, m), 4.86 (1H, d, J 15.6), 5.33 (1H, d, J 15.6), 5.95 (1H,
t, J 6.4), 7.04-7.40 (9H, m); δC (100 MHz, CDCl3) 21.0, 35.6,
51.7, 123.2, 123.3, 124.9, 126.7, 126.9, 127.0, 127.8, 128.3, 135.1,
135.5, 140.3, 171.4; m/z (EI) 263 (M+, 10%), 221 (100), 91 (28).
1-Benzyl-5-ethyl-1,3,4,5-tetrahydro-1-benzazepin-2-one, 19.
δH (400 MHz, CDCl3) 0.74 (3H, t, J 7.3), 1.47-1.58 (2H, m), 1.67-
1.78 (1H, m), 2.15-2.32 (2H, m), 2.34-2.42 (2H, m), 4.74. (1H,
d, J 14.6), 5.26 (1H, d, J 14.6), 7.14-7.29 (9H, m); δC (100 MHz,
CDCl3) 12.1, 24.7, 33.2, 35.8, 51.3, 123.2, 125.3,126.5, 126.9,
127.3, 128.3, 128.3, 137.7, 138.3, 142.6, 173.3; m/z (EI) 279 (M+,
100%), 91 (80%).
Benzyl-6-methyl-3,4,5,6-tetrahyro-1H-1-benzazocin-2-one, 20.
Obtained by hydrogenation of 12. Yield: 95% as a white solid;
mp 96-97 °C; νmax(KBr)/cm-1 1645 (CO). Found: C, 81.67; H,
7.55; N, 4.98. Calcd for C19H21NO: C, 81.68; H, 7.58; N, 5.01. δH
(270 MHz, CDCl3): 0.88 (3H, d, J 7.0), 1.17-1.27 (1H, m), 1.66-
1.74 (1H, m), 1.76-1.86 (2H, m), 1.87-1.96 (1H, m), 2.06-2.16
(1H, m), 2.22-2.27 (1H, m). 4.47 (1H, d, J 13.7), 5.45 (1H, d, J
13.7), 7.14-7.31 (9H, m); δC (100 MHz, CDCl3): 21.9, 25.3, 32.3,
33.1, 37.8, 52.4, 125.6, 126.0, 126.6, 127.4, 128.2, 128.3, 129.3,
136.4, 140.0, 146.0, 174.2; m/z (EI) 279 (M+, 100%), 91 (100%).
Hex-5-enoic Acid Benzyl-phenyl-amide, 21. A pure sample was
obtained via an independent route by the amidation of hex-5-enoic
acid by N-benzylaniline. Colorless oil. νmax(thin film)/cm-1 1657
(CO). Found: C, 81.80; H, 7.63; N, 5.00. Calcd for C19H21NO: C,
81.68; H, 7.58; N, 5.01. δH (270 MHz, CDCl3): 1.58-1.74 (2H,
m), 1.95-2.11 (4H, m), 4.88-4.95 (4H, m), 5.63-5.71 (1H, m),
6.95-6.97 (2H, m), 7.14-7.41 (8H, m); δC (100 MHz, CDCl3):
24.6, 33.1, 33.6, 33.6, 52.9, 114.8, 127.2, 127.8, 128.3, 128.4, 128.8,
129.4, 137.6, 138.1, 142.4, 172.7; m/z (EI) 279 (M+,34%), 183
(88), 180 (55), 91 (100).
Acknowledgment. The authors thank AstraZeneca and
EPSRC for the award of an industrial Doctoral Training Grant
(GR/P01816/01), and Johnson Matthey plc for the loan of
palladium salts.
Supporting Information Available: Description of general
experimental procedures, preparation of precursors 6-9, selected
NMR spectra and X-ray crystallographic data, and CIF files for
compounds 11 and 12. This material is available free of charge via
(24) Kaslow, C. E.; Cook, D. J. J. Am. Chem. Soc. 1945, 67, 1969.
JO0522660
J. Org. Chem, Vol. 71, No. 4, 2006 1735